Symposium

Event Schedule

Symposium

  • DAY 2
    Saturday NOV 15
Time Schedule Schedule
08.00 - 09.00
SYMPOSIUM 1:
Emergency Chest Pain Dilemmas: Spotting Myocardial Infarction Without Missing the Real Threat
SYMPOSIUM 2:
Cardiovascular Disease in Specific Population: Focus On Women and Pregnancy
08.00 - 08.15 When Myocardial Infarction Mimics Non-myocardial Infarction: ECG Clues for Occlusive vs. Non-Occlusive MI Navigating Pregnancy with Heart Disease : Current Perspectives
08.15 - 08.30 When Non-ACS Looks Like ACS: Avoiding Pitfalls in Diagnosis & Management Ensuring Maternal & Fetal Safety: Pregnancy Challenges in Women with Congenital Heart Disease
08.30 - 08.45 From Bench to Bedside: The 2025 ESC Playbook for Myocarditis & Pericarditis Cardiovascular Diseases in Women: Choosing Effective yet Safe Women Contraceptives
08.45 - 09.00 Discussion Discussion
09.00 - 09.30 Opening Ceremony
09.30 - 10.10 Plenary Session
10.10 - 10.25 Coffee Break
10.25 - 11.25
SYMPOSIUM 3:
Hypertension Updates: Cut-off Blood Pressure and Treatment
SYMPOSIUM 4:
Beta Blocker in Hypertensive Emergencies
10:25 - 10:40 Elevated Blood Pressure : New Concept in Hypertension The Pathophysiology of Hypertensive Emergency: A Focus on the Sympathetic Nervous System
10:40 - 10:55 Monotherapy vs Fixed Dose Combination in Hypertension : Choosing Right Therapy For Different Population Current Updates in the Diagnosis and Treatment of Hypertensive Emergencies
10:55 - 11:10 Hypertension Screening in Children to Prevent Premature Cardiovascular Mortality Revisiting the Role of Intravenous Beta-blocker in Hypertensive Emergency Management
11:10 - 11:25 Discussion Discussion
11:25 - 12:25
LUNCH SYMPOSIUM 1 :
A-Z Comprehensive Management of Heart Failure to Improve Patient Outcomes
LUNCH SYMPOSIUM 2:
From Guidelines to Game-Changers: Comprehensive ASCVD Management and the Transformative Role of PCSK9-Inhibitors
11:25 - 11:45 Bridging evidences of Dapagliflozin mortality benefit in heart Failure across ejection fractions and sub-populations The Call for Comprehensive ASCVD Management: Latest Updates in Dyslipidemia Guidelines
11:45 - 12:05 Advancing hyperkalemia management with novel potassium binders to optimize GDMT and cardiorenal protection Transformative role of PCSK9-Inhibitor: Breakthrough in modern lipid management
12:05 - 12:25 Discussion Discussion
12:25 - 13:25 LUNCH BREAK
13:25 - 14:30
SYMPOSIUM 5:
Revascularization in Heart Failure Patient
SYMPOSIUM 6:
Syncope Management in Daily Practice
13:25 - 13:45 Mechanism of Myocardial Ischemia Transient Loss of Consciousness: Syncope or Not Syncope
13:45 - 14:00 How to deal with Microvascular Angina ⁠Managing Vasovagal Syncope
14:00 - 14:15 The Benefit of Long term Beta-blocker treatment Post MI ⁠Red Flag ECG Findings in Syncope
14:15 - 14:30 Discussion Discussion
14:30 - 15:30
SYMPOSIUM 7:
Structural and Valvular Heart Diseases (Case-based debate session)
SYMPOSIUM 8:
Flying to The Heart Failure Galaxy
14:30 - 14:45 The Role of Pharmacological Therapy in Aortic Valve Disease: Scientifically Proven or Just Common Beliefs? Cardiac Remodelling in Heart Failure : What Do We Know So Far?
14:45 - 15:00 Intervention for Aortic Valve Diseases: Transcatheter vs. Surgery Heart Failure with Recovered Ejection Fraction : Business as Usual or Else?
15:00 - 15:15 Is it a bioprosthetic or mechanical valve? Optimizing Aortic Valve Replacement in the Elderly Conquering The Heart Failure Continuum : The Guardiance of The All
15:15 - 15:30 Discussion Discussion
15:30 - 15:45 Coffee Break
14:30 - 15:30
SYMPOSIUM 9:
Closing the Gap: Iron Deficiency Management in Heart Failure
CARDIOLOGY COMPETITION (CARDIOLOGY JEOPARY)
15:45 - 16:00 Pathophysiology and Clinical Impact of Iron Deficiency in Heart Failure
16:00 - 16:15 Diagnosis Strategies and Biomarkers of Iron Deficiency in Heart Failure
16:15 - 16:30 Therapeutic Approaches : Evidence and Guideline for Iron Repletion in Heart Failure
16:30 - 16:45 Discussion
16:45 - 17:15 Closing Ceremony, Announcements, Doorprizes
19:00 - 20:00 HOMECOMING SESSION
DINNER SYMPOSIUM : Advancing Heart Failure Management for Better Survival
19.00 - 19.20 SGLT2i : the cardiorenometabolic evidence
19:20 - 19:40 Neurohormonal Modulation in Heart Failure: The Robust Evidence Behind Modern Therapies
19:40 - 20:00 Discussion